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Abstract
Background: A history of early adverse experiences is an important risk factor for adult psychopathology. Changes in stress
sensitivity and functioning of the hypothalamic-pituitary-adrenal (HPA) axis may underlie the association between stress
and risk for psychiatric disorders. Preclinical work in rodents has linked low levels of maternal care to increased methylation
of the promoter region of the glucocorticoid receptor (GR) gene, as well as to exaggerated hormonal and behavioral
responses to stress. Recent studies have begun to examine whether early-life stress leads to epigenetic modifications of the
GR gene in humans.
Methods: We examined the degree of methylation of a region of the promoter of the human GR gene (NR3C1) in leukocyte
DNA from 99 healthy adults. Participants reported on their childhood experiences of parental behavior, parental death or
desertion, and childhood maltreatment. On a separate day, participants completed the dexamethasone/corticotropin-
releasing hormone (Dex/CRH) test, a standardized neuroendocrine challenge test.
Results: Disruption or lack of adequate nurturing, as measured by parental loss, childhood maltreatment, and parental care,
was associated with increased NR3C1 promoter methylation (p,.05). In addition, NR3C1 promoter methylation was linked to
attenuated cortisol responses to the Dex/CRH test (p,.05).
Conclusions: These findings suggest that childhood maltreatment or adversity may lead to epigenetic modifications of the
human GR gene. Alterations in methylation of this gene could underlie the associations between childhood adversity,
alterations in stress reactivity, and risk for psychopathology.
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Introduction
Many decades of research in rodents, non-human primates, and
humans have documented the impact of early experiences on the
neurobiological mechanisms regulating stress responses and mood
and anxiety disorders. Young children are dependent on
caregivers for their basic physical, social and emotional needs,
and in addition undergo substantial developmental changes in
neural pathways involved in regulating emotion and behavior. As
a result, disruption of early care-giving can produce profound and
long-lasting changes in these neurobiological and behavioral
systems [1–3]. Early-life stress is a risk factor for major depression,
post-traumatic stress disorder, and drug abuse, among other
conditions [4,5].
Alteration of basal and stress-induced activity of the hypotha-
lamic-pituitary-adrenal (HPA) axis is implicated in the pathogen-
esis of these disorders. Chronic alterations of HPA axis activity
have been shown in rodents and non-human primates exposed to
disruptions of parental care such as maternal separation [6,7] and
maternal neglect [8], and in humans with childhood parental loss,
and neglect or other forms of childhood maltreatment [2,9–17].
Elevated glucocorticoids impair neuronal growth and survival
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and accelerate cellular aging [19,20], all of which have been
associated with both early-life stress [18,21–23] and major
depression [18,24–26].
Preclinical work implicates epigenetic changes to the gene for
the type II glucocorticoid receptor (NR3C1) as a mechanism
underlying the neuroendocrine effects of environmental adversity.
Epigenetic alterations to DNA influence gene expression but do
not change the nucleotide sequence of DNA. Methylation is a
stable form of epigenetic modification which alters gene expression
via effects on transcription factor binding [27]. Methyl residues
chemically modify regions of DNA where a cytosine nucleotide
occurs next to a guanine nucleotide via a phosphodiester bond
(CpG sites). As reviewed by Weaver [27] and Champagne and
Curley [28], low levels of maternal care in rodents result in greater
methylation of the promoter region of the hippocampal glucocor-
ticoid receptor (GR) gene (exon 17 of the NR3C1 promoter), which
interferes with binding of nerve growth factor inducible protein A
(NGFI-A), a transcription factor. Greater methylation reduces
NR3C1 gene expression, which results in decreased numbers of
GRs in the hippocampus and exaggerated hormonal and
behavioral sequelae of stress.
Two published investigations have examined associations of
early experiences with epigenetic modification of the promoter of
the human GR gene NR3C1. Both studies focused on the exon 1F
region of the promoter, which is homologous to the rat exon 17
and contains the NGFI-A binding site. Oberlander and colleagues
[29] examined mixed mononuclear cells from cord blood of 82
infants and found that increased maternal depressed mood in the
third trimester was linked to increased methylation at CpG 1 and 2
in this region, as well as CpG 3, an NGFI-A binding site. CpG 3
methylation was also positively associated with salivary cortisol
responses to infant stimulation at three months.
The second human study on this topic examined DNA from
postmortem hippocampal tissue from 36 men [30]. Proxy-based
retrospective interviews identified 12 suicide victims with a history
of childhood abuse, 12 suicide victims without abuse, and 12
control subjects without known abuse who died from another
cause. The suicide/abuse victims had increased cytosine methyl-
ation of the NR3C1 promoter and decreased levels of GR mRNA
compared to the other groups. Patch-methylated NR3C1 promoter
constructs that mimicked enhanced DNA methylation showed a
corresponding decrease in binding of NGFI-A and NGFI-A–
inducible gene transcription. These findings suggest that childhood
abuse may result in decreased transcription of hippocampal GR in
humans.
Based on the compelling body of preclinical work, the two
previous studies in humans, and our prior findings of enduring
neuroendocrine alterations in adults with a history of childhood
adversity, we conducted the present study to test the hypothesis that
increased leukocyte NR3C1 promoter methylation is associated with
adverse childhood experiences and with attenuated cortisol
responses to a standardized neuroendocrine challenge test. We
report here that childhood adversity is associated with greater
NR3C1 methylation, and that individuals with greater levels of
NR3C1 methylation have attenuated cortisol responses to the
dexamethasone (Dex)/corticotropin-releasing hormone (CRH) test.
Materials and Methods
Ethics Statement
This study was approved by the Butler Hospital Institutional
Review Board, and after complete description of the study to the
subjects, written informed consent was obtained.
Subjects
Ninety-nine participants, 58 women and 41 men, aged 18–59
(27.3610.4) years, were recruited for several related studies of
stress and HPA axis function using local, newspaper, and internet
advertisements directed toward healthy adults, individuals with a
history of early parental loss, and adults with a history of early-life
stress. Subjects were compensated $175 for their time and effort
spent participating in the study.
Following a telephone screening to determine preliminary
eligibility, participants completed a medical history, physical
examination, neurological examination, electrocardiogram, and
standard laboratory studies to rule out pregnancy or major
medical illness, including, but not limited to, endocrine disease,
allergy symptoms, or a history of brain injury or seizures. Also
excluded were individuals with use of psychotropics, beta blockers,
angiotensin-converting enzyme inhibitors, ketoconazole, metyra-
pone, or corticosteroids. Oral contraceptives were allowed, with
usage accounted for in analyses of cortisol concentrations.
Demographic Characteristics
In addition to age and sex, we measured weight and height and
calculated body mass index [BMI, weight (Kg)/height (M)
2].
Because we were interested in the socioeconomic conditions of the
adult participants during their childhood, we used the following
statements to determine socioeconomic adversity: 1) I grew up in
an area of high crime; 2) My family was generally financially stable
when I was growing up, and all of my basic needs (food, shelter,
and clothing) were met during my childhood. Sixteen subjects
were considered to have socioeconomic adversity during child-
hood based on adverse scores on either of these statements.
Behavioral and Stress Measures
Psychiatric Symptoms and Diagnoses. Axis I psychiatric
diagnoses were assessed using the Structured Clinical Interview for
DSM-IV [SCID; [31], and participants were excluded if they met
criteria for any current or past disorder except simple phobia in
order to isolate effects of early adversity. The Inventory for
Depressive Symptoms, Self Report [32], the State-Trait Anxiety
Inventory [33], and the Perceived Stress Scale [34] were included
to assess subclinical symptoms and recent perceived stress.
Parental Bonding Index: Parental Care [35]. The
Parental Bonding Index assesses parenting as perceived by the
child and assessed retrospectively in adulthood. A higher score on
the ‘‘Care’’ factor reflects parental warmth, affection, and
involvement, while a lower score reflects greater parental
coldness, rejection, and detachment. This measure has high
stability and validity over 20 years of follow-up and is not
substantially influenced by depressed mood or neuroticism
[35,36]. The mean of the maternal and paternal scales was used
for assessment of Parental Care.
Childhood Parental Loss. Loss of a parent before age 18
(N=22) included death (N=12) and/or prolonged separation/
desertion (i.e., parent deserted for at least six months with no
attempts at contact or responses to child’s attempts (N=14)).
The Childhood Trauma Questionnaire, 28-item version
[37]. This measure generates a total score summarizing five
types of childhood maltreatment (physical, sexual, and emotional
abuse, physical and emotional neglect), with high internal
consistency, test-retest reliability, and convergent validity [38].
NR3C1 Promoter Methylation Sequencing
DNA was extracted using standard methods from whole blood.
Blood samples were thawed only once for DNA extraction, and
modified DNA was thawed only once prior to sequencing. Sodium
GR Epigenetic Modulation and Childhood Adversity
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Methylation Kit (Zymo Research, Orange, CA) following the
manufacturer’s protocol. Methylation at the NR3C1 promoter
region was examined with a quantitative pyrosequencing ap-
proach following the method of Oberlander and colleagues [27].
The region analyzed contains 13 CpGs and encompasses exon 1F,
the human homologue of the rat exon 17 (Figure 1). Sodium
bisulfite-modified, fully-methylated referent positive control and
fully-unmethylated (whole genome amplified) negative control
DNA (Qiagen, Valencia CA) was examined with each batch.
Peripheral blood lymphocyte DNA that was not sodium bisulfite-
modified served as a control for non-specific amplification.
Methylation quantification was performed using the Pyromark
Software (Qiagen). The percent of alleles that were methylated in
the cell population examined was used in statistical analyses.
Dex/CRH Test
On a subsequent visit, 88 participants completed the Dex/CRH
test. The night before the test, an oral dose of dexamethasone
1.5 mg was self-administered at 11 p.m. The following day,
subjects arrived at 12:00 p.m. and were given lunch. A topical
anesthetic (lidocaine 2.5% and prilocaine 2.5%) was applied to the
subject’s forearm between 12:30 and 12:45 p.m. At 1:00 p.m. an
indwelling intravenous (IV) catheter was inserted in the forearm by
a highly experienced research nurse. Subjects then remained in a
semi-recumbent position throughout the procedure except to use
the bathroom. They were permitted to read or watch pre-selected
films that did not contain emotionally-charged material. Vital
signs were monitored throughout the test. At 3:00 p.m., CRH
100 mg (corticorelin ovine triflutate, Acthrel, Ferring Pharmaceu-
ticals, Inc.) reconstituted in 2 ml of 0.9% NaCl solution was
infused intravenously over 30 seconds. Blood samples were drawn
at 2:59 p.m., 3:30 p.m., 3:45 p.m., 4:00 p.m., 4:15 p.m., and 5:00
p.m. and assayed for cortisol.
Hormone Assays
Plasma cortisol concentrations were assayed in duplicate using
the Gamma Coat cortisol I-125 coated-tube radioimmunoassay kit
(INCSTAR Corp., Stillwater, Minnesota). Intra-assay and inter-
assay CVs observed for quality assessment samples (5 and 20 mg/
dL) were less than 5% and 10%, respectively. Area under the
curve over time for cortisol was calculated and log transformed
due to positive skew.
Statistical Analysis
To minimize the number of comparisons and mitigate the
possibility of type I statistical errors, we selected a small number of
relatively distinct domains of childhood adversity and CpG sites
for a priori hypotheses regarding the effect of adversity on CpG
methylation. Childhood adversity measures included Maltreat-
ment (Childhood Trauma Questionnaire total score), Parental
Care (subscale of the Parental Bonding Instrument), and Parental
Loss (dichotomous). As expected, these measures were moderately
inter-correlated (correlations with other adversity measures for
Parental Loss were r=.27 and .30, Parental Care r=.27 and .65,
and Maltreatment r=.30 and .65). Although the Maltreatment
and Parental Care domain scales showed substantial intercorre-
lations, the magnitude of the correlations revealed substantial
unique variance, indicating that the three childhood adversity
measures were not redundant. To test for combined effects of these
variables, an Adversity Index was composed of the three childhood
adversity variables, with one point each for Parental Loss,
Maltreatment (upper tertile of the distribution), and Low Parental
Care (lower tertile of the distribution). The distribution of scores
on this sum scale for number of adversity experiences was as
follows: 0, N=52; 1, N=17; 2, N=20; and 3, N=10.
We selected CpG sites 1–3 in this region based on the findings
of Oberlander and colleagues [27], and we also included CpG 4,
because NGFI-A binds at CpG 3 and 4. Intercorrelations of
methylation at CpG sites 1–4 were relatively small (r=.05–.38),
indicating that these sites are regulated in a largely independent
fashion. Following Oberlander and colleagues, we examined
additional CpG sites in this region (CpG 5–13) in an exploratory
fashion, and we regard any findings as hypothesis-generating.
CpG sites 5 and 6 had small associations with all other CpG sites
(range r=2.09–.33). CpG sites 7–13 showed small associations
with CpG sites 1–6 (range r=2.04–.33), but were very highly
intercorrelated (r=.32–.85; each CpG site had at least one
correlation with another of these sites that was greater than 0.5,
and several were in the .7 and .8 range). Therefore, we calculated
the mean percent methylation for CpG 7–13 and used this single
variable in the exploratory analyses.
Outliers, defined as values more than three standard deviations
from the mean were Winsorized by setting them to the next
highest value within three standard deviations. There were three
outliers for CpG 2, two outliers for CpG 3, and one outlier for
CpG 4. Of the exploratory sites, there was one outlier for CpG 6
and two outliers for the mean of CpG 7–13. Demographic
characteristics, as well as recent perceived stress levels and
subsyndromal symptoms of depression and anxiety, were exam-
ined and controlled when statistically significant. Partial correla-
tions were used to test for associations of the continuous adversity
variables and the Adversity Index. For the dichotomous Parental
Loss variable, analysis of covariance was used to test for effects, but
partial correlations were displayed in the table for consistency.
Results
Potential Covariates
Age was correlated with greater methylation at several CpG sites.
Age was also associated with scores on the Parental Care scale and
Childhood Trauma Questionnaire, so we controlled for age in the
analyses. Age, sex, and estrogen use, known determinants of cortisol
response, were controlled in analyses of cortisol responses. BMI,
estrogen use, and childhood socioeconomic adversity were not
Figure 1. Schematic representation of human NR3C1 59
regulatory region, and the specific region analyzed by bisulfite
pyrosequencing. The upper diagram represents the multiple first
exons, and the second exon (2) which represents the translational start.
All numbering is based on the translational start site (+1), which is
located 13 nucleotides within the start of exon 2. The lower region is
the region analyzed by pyrosequencing, with the 13 CpG sites in bold
and numbered above the sequence, and the full exon 1F region
underlined.
doi:10.1371/journal.pone.0030148.g001
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considered further in the analyses.
Childhood Adversity and Percent Methylation at
Hypothesized CpG Sites
The partial correlations and analyses of covariance, adjusting
for age and testing effects of childhood adversity variables at CpG
sites 1–4, are shown in Table 1 and depicted in Figure 2. Greater
methylation at CpG 1 was associated with lower levels of Parental
Care and with Parental Loss (r=2.23, p=.03 and F=5.9,
p=.02, respectively). Methylation at CpG 2 was not associated
with any of the childhood adversity variables. Greater methylation
at CpG 3 was linked to Maltreatment (r=.23, p=.03), as well as
to Parental Loss (F=8.2, p=.005). Methylation at CpG 4 was not
significantly associated with any of the adversity variables.
Similarly, the Adversity Index was positively correlated with
CpG 1 (r=.22, p=.03) and CpG 3 (r=.22, p=.04), but not CpG
2o r4 .
Childhood Adversity and Percent Methylation at
Exploratory CpG Sites
Exploratory analyses of methylation at CpG sites 5, 6 and the
mean of CpG 7–13 did not reveal any effects of childhood
maltreatment, quality of parenting, or loss of parent, although
there was a trend for low Parental Care to be associated with
greater methylation at CpG 5 (p=.065). The Adversity Index was
not associated with these exploratory sites.
Dex/CRH Test and Methylation at Hypothesized and
Exploratory CpG Sites
Partial correlations, controlling for age, sex, and estrogen use,
revealed a negative association of cortisol area under the curve
with percent methylation at CpG 2 (r=2.23, p=.03, Figure 3).
Methylation at CpG sites 1, 3, and 4 were not associated with
cortisol response to the Dex/CRH test. The exploratory CpG sites
5 and the mean of 7–13 both showed negative associations with
cortisol response (r=2.25, p=.03 and r=2.23, p=.04, respec-
tively; Figure 3).
Subsyndromal Symptoms and Current Stress
Partial correlations, controlling for age, revealed that subsyn-
dromal symptoms of depression and anxiety, as indexed by the
Inventory for Depressive Symptoms Self Report and the State-
Trait Anxiety Inventory, were not significantly associated with
methylation at any of the four predicted CpG sites. There was a
trend-level association of increased methylation at CpG4 with
depressive symptoms (p=.056), but controlling for depressive
symptoms did not alter any of the childhood adversity or cortisol
findings. Perceived stress showed a significant positive association
with methylation at one site, CpG 2 (r=.23, p=.03), but
controlling for this variable did not alter the adversity findings
or the cortisol findings.
For the exploratory CpG sites, neither state-trait anxiety nor
recent perceived stress was associated with methylation. Subsyn-
dromal depressive symptoms showed a significant negative
association with methylation at CpG 6 only (r=2.20, p=.049),
but controlling for this variable did not substantively change any of
the adversity or cortisol results at the exploratory CpG sites.
Discussion
We found that healthy adults reporting a history of childhood
adversity (loss of a parent, maltreatment, poor quality parenting)
had increased cytosine methylation of the promoter region of the
GR gene NR3C1. In addition, methylation of this region was
associated with attenuated cortisol responses to the Dex/CRH test
in adulthood. This is the first study to demonstrate that variation
in human parenting experiences is linked to epigenetic modulation
of the leukocyte GR gene. Our results are consistent with findings
of the two prior human studies (using hippocampal tissue and
infant cord blood, respectively) of epigenetic modulation of this
gene in association with childhood maltreatment [30] and prenatal
exposure to maternal depressed mood [29]. In rodents, low levels
of maternal care during early postnatal life are associated with
increased cytosine methylation and decreased expression of the
hippocampal GR (NR3C1) promoter [27]. Given previous findings
on childhood maltreatment and loss on risk for psychopathology,
the effect of promoter methylation on GR expression and
glucocorticoid responses, and the role of HPA axis dysfunction
in depressive and anxiety disorders, the present findings suggest
that epigenetic changes to this gene could be a key mechanism for
effects of childhood adversity on risk for these disorders.
The transcription factor NGFI-A binds at CpG 3 and 4, and we
found that CpG 3 methylation was associated with loss of a parent
and maltreatment in childhood. Methylation at CpG 4 was not
significantly linked to these adversity measures. Our findings
extend the observations of Oberlander and colleagues [27], who
found that cytosine methylation at CpG 3 was associated with
exposure to maternal depression in the third trimester, and with
increased infant cortisol responses. Methylation at this site may
alter transcription; methylation at the NGFI-A binding site in
hippocampus has been shown to reduce GR expression in rodents
[39–41] and humans [27,30]. However, this site was not
methylated in mice treated with oral corticosterone [42] or rat
pups subjected to maternal separation [43]. In humans, one study
found that the NGFI-A binding site was unmethylated in post
mortem hippocampal tissue from 32 individuals, most with
Parkinson’s or Alzheimer’s disease, but no information on early
environmental stressors was available in this study [44]. A recent
examination of post-mortem brain from donors with major
depression (but without documented child abuse) found reduced
expression of hippocampal NR3C1 exon 1F [45]. However,
promoter 1F was uniformly unmethylated and instead, NGFI-A
was downregulated. This suggests that while altered GR
transcription may be common to childhood abuse and major
depression without early adversity, the mechanism may differ in
the two conditions.
Our findings of greater methylation at CpG 1 in association
with low Parental Care and with loss of a parent in childhood also
Table 1. Associations of Childhood Adversity Measures and
Percent Methylation at Hypothesized CpG Sites (1–4).
CpG 1 CpG 2 CpG 3 CpG 4
Maltreatment .173 .103 .228 .171
.097 .324 .028 .102
Parental Care 2.234 .069 2.084 2.094
.026 .516 .429 .377
Parental Loss .228 .057 .257 .059
.030 .593 .014 .576
Note: Statistic represents partial correlation coefficients (r) controlling for age. P
values are shown underneath the coefficients. Significant and trend-level effects
are highlighted in bold.
doi:10.1371/journal.pone.0030148.t001
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infant methylation of CpG 1 in association with maternal depressed
mood in the third trimester. The additive Adversity Index was also
positively correlated with both CpG 1 and 3, indicating that a
greater number of different adverse childhood experiences is
associated with more methylation at NR3C1. Our findings appear
to be specific to early environment stress and are not accounted for
by current psychopathology or subsyndromal symptoms.
None of our adversity measures was significantly associated with
methylation at CpG 2 or the exploratory CpG sites (although there
was a trend for low Parental Care to be associated with greater
methylation at CpG 5). Cortisol response to the Dex/CRH test
showed negative associations with CpG site 2 and the exploratory
sites CpG 5 and the average of sites 7–13. That we found attenuated
cortisol responses contrasts with findings of enhanced cortisol
responses in rodents with increased NR3C1 promoter methylation
and decreased receptor expression [27], as well as with increased
cortisol responses in infants with greater cytosine methylation at
CpG 3 [29]. It therefore seems unlikely that our cortisol findings
are a direct effect of methylation-induced decreases in GR
Figure 2. Significant Associations of Childhood Adversity Variables and Percent Methylation at Predicted CpG Sites (1–4). The
Parental Care scale of the Parental Bonding Instrument reflects parental warmth, affection, and involvement; lower scores reflect greater parental
coldness, rejection, and detachment. Maltreatment reflects the total score of Childhood Trauma Questionnaire. Parental loss is defined as loss of a
parent before age 18, including death (N=12) and/or prolonged separation/desertion (N=14).
doi:10.1371/journal.pone.0030148.g002
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blunted cortisol responses in association with early-life stress from
our group [12–14,46] and others (e.g., [16,47]). The mechanism of
this effect is unknown, but may involve a trajectory of initial hyper-
activationoftheHPAsystem inresponsetoexcessiveand prolonged
stress exposure progressing to a counter-regulatory adaptation state
of chronic adrenal stress hyporeactivity [6,48,49]. This may be
influenced by the developmental timing or chronicity of early-life
stress; unfortunately we do not have these measures in the present
study. We do not have gene expression data in this sample, and our
measure of HPA axis function was limited to the Dex/CRH test.
Thistest is a sensitivemeasureof HPAaxis dysfunction,butbecause
it combines a large dose of dexamethasone with corticotropin-
releasing hormone administration, it does not permit assessment of
feedback sensitivity or other specific components of the axis that
may explain the findings. Possible mechanisms include compensa-
tory down-regulation of corticotropin-releasing hormone or adre-
nocorticotropic hormone receptors, or increases in GR negative
feedback sensitivity, in response to or in addition to changes in GR
expression.
Exposure to stress and trauma are increasingly thought to
underlie the neuroendocrine abnormalities seen in some patients
with depressive and anxiety disorders. Abnormal HPA axis activity
may play a central role in the pathogenesis of depressive and
anxiety disorders, perhaps in those with excessive stress exposure.
Preclinical studies show that chronic stress and glucocorticoid
administration result in hippocampal atrophy [50], which has also
been documented in adults with a history of childhood
Figure 3. Significant Associations of Cortisol AUC in the Dex/CRH Test and Percent Methylation at CpG Sites. AUC is defined as Area
Under the Curve.
doi:10.1371/journal.pone.0030148.g003
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[50,51]. In contrast, stress and glucocorticoids can produce
excitability and dendritic remodeling in the amygdala, which
mediates anxiety and fear responding [52]. Thus, alterations in
HPA axis activation in response to early deprivation may alter the
structure and activity of brain regions involved in mood and
anxiety disorders. We excluded individuals with current or past
Axis I psychiatric disorders in the current study. This allowed us to
isolate the effects of early adversity, but it is important to note that
this exclusion likely resulted in a sample of individuals who are
especially resilient to psychopathology, in addition to those who
are at risk but have not yet developed a disorder.
In this study we examined the leukocyte GR gene, whereas the
previous human investigations of the effect of exposures examined
cord blood or hippocampal tissue. The similarity of our findings to
those of the prior human studies, as well as animal work on the
hippocampal GR in relation to variation in maternal care, is
encouraging, but data regarding the differential control of
expression of the GR in various tissues are very limited. Some
evidence indicates similarities in the regulation of this gene in
brain and peripheral tissues. Lee and colleagues [42] found that
chronic oral corticosterone administration caused anxiety-like
behavior and a decrease in hippocampal and blood mRNA levels
of NR3C1. Moreover, the relevance of regulation of leukocyte
glucocorticoid receptor expression for stress-related disorders is
supported by evidence of abnormal sensitivity and expression of
this receptor in leukocytes of patients with major depression and
post-traumatic stress disorder [53,54].
Our findings of age-related alterations to the extent of
methylation are consistent with other reports that identify gene-
specific associations between methylation and aging [55,56]. In
addition, in this sample, older subjects reported higher levels of
Maltreatment and lower Parental Care than younger participants
(and age was controlled in the analyses). This may be a cohort
effect, but it is possible that it is due to an age-related reporting or
memory bias. We studied several related childhood experiences
that commonly co-occur and may have similar or redundant
epigenetic effects. It is notable that the Adversity Index, the sum of
the various childhood adversities, was positively associated with
the degree of NR3C1 methylation. Childhood parental loss, which
represents a more objective event than some other types of
experiences and is less likely to co-occur with maltreatment than
other forms of adversity, was the strongest predictor of CpG
methylation (and was not associated with age). It should be noted
that the effects of childhood parental loss may be mitigated by
personal and familial characteristics that influence adaptation to
loss (e.g., [14,57]).
Because we studied a mixed population of leukocytes, our
findings could be influenced by the relative composition of these
cells, which can be altered during infection and other conditions.
Glucocorticoids have strong anti-inflammatory effects, and
glucocorticoid receptors are present in several leukocyte cell types,
including lymphocytes, neutrophils, eosinophils, and macrophages
[58]. However, it is unlikely that inflammatory conditions explain
our findings because 1) we excluded subjects with acute or chronic
illness, allergy symptoms, abnormal blood counts, or the use of
antibiotics, antihistamines, or corticosteroids, and 2) any such
confounding effect would have to occur differentially in those with
adversity.
In summary, we found that early-life stress, in the form of loss of
a parent during childhood, maltreatment, and low parental care,
was associated with epigenetic changes to the promoter region of
the glucocorticoid receptor gene. In addition, methylation of the
promoter region of this gene was linked to alterations in HPA axis
function. These findings, together with previous research in
rodents and two prior studies in humans, provide preliminary
support for the hypothesis that altered expression of the
glucocorticoid receptor due to cytosine methylation of the gene
promoter could be a mechanism of the neuroendocrine effects of
early-life stress, and could predispose to the development of major
depression and post-traumatic stress disorder. However, our effect
sizes tended to be modest in magnitude, different CpG sites were
associated with the associations of childhood adversity measures
and the cortisol response to the Dex/CRH test, and we did not
have gene expression data available. This study will need to be
replicated in order to draw firm conclusions about the findings.
Further work is also needed to determine whether these findings
are specific to lymphocytes and whether this reflects changes in
central regulation of the glucocorticoid receptor in brain regions
involved in stress responses and mood and anxiety disorders.
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